Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Investigating Glutamate and Opioid Mechanisms of Antidepressant Response to Ketamine


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT04977674

Organisation Name: King's College London

Overal Status: Not yet recruiting

Start Date: August 2021

Last Update: July 27, 2021

Lead Sponsor: King's College London

Brief Summary: The overarching aim of this research is to determine the acute effects of ketamine on brain glutamate, functional connectivity and cerebral blood flow in treatment-resistant depression, explore whether the effects are attenuated by the opioid receptor antagonist naltrexone and relate these findings to antidepressant response.

Conditions:
  • Depressive Disorder, Treatment-Resistant


Total execution time in seconds: 0.18800497055054